Literature DB >> 1430582

Protein C and S deficiency in severe infectious purpura of children: a collaborative study of 40 cases.

F Leclerc1, J Hazelzet, B Jude, W Hofhuis, V Hue, A Martinot, E Van der Voort.   

Abstract

We studied, in 40 children (mean age: 52 months) with severe infectious purpura, the relationships between protein C (PC) and protein S (PS) levels, and shock, disseminated intravascular coagulation (DIC) and outcome. We determined, on admission, PC antigen (ELISA) and activity (chromogenic test), and total PS (ELISA). Results were expressed as % of normal adult values. Statistical analysis was performed with SAS. Thirty children were in shock, 20 had DIC. All children with DIC, and 10 without DIC were in shock. Of 20 children who were in shock and had DIC, 7 died and 3 had an amputation. PC antigen was significantly decreased in shock children (p less than 0.05), in children with DIC (p less than 0.0005), and in non-survivors (p less than 0.05). PC activity was significantly decreased in shock children (p less than 0.05), in children with DIC (p less than 0.0005), and in non-survivors (p less than 0.005). Total PS was not decreased in shock children, but was significantly decreased in children with DIC (p less than 0.005), and in non-survivors (p less than 0.005). We conclude that PC and PS levels were decreased in our children, and that PC levels were significantly decreased in the presence of shock, DIC, and fatal outcome. PC and antithrombin III (AT III) supplementation, should be evaluated in children with severe infectious purpura with shock and DIC.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1430582     DOI: 10.1007/bf01709832

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  22 in total

1.  Neonatal purpura fulminans associated with homozygous protein S deficiency.

Authors:  C Mahasandana; V Suvatte; R A Marlar; M J Manco-Johnson; L J Jacobson; W E Hathaway
Journal:  Lancet       Date:  1990-01-06       Impact factor: 79.321

Review 2.  The regulation of hemostasis: the protein C system.

Authors:  L H Clouse; P C Comp
Journal:  N Engl J Med       Date:  1986-05-15       Impact factor: 91.245

3.  Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease.

Authors:  P Brandtzaeg; G B Joø; B Brusletto; P Kierulf
Journal:  Thromb Res       Date:  1990-01-15       Impact factor: 3.944

Review 4.  [Purpura fulminans in children. Current aspects].

Authors:  F Leclerc
Journal:  Arch Fr Pediatr       Date:  1987-02

5.  Recombinant human protein C: comparative functional studies with human plasma protein C.

Authors:  R M Madden; C Oppenheimer; R Wydro; R A Marlar
Journal:  Thromb Res       Date:  1990-02-01       Impact factor: 3.944

6.  Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon.

Authors:  F B Taylor; A Chang; C T Esmon; A D'Angelo; S Vigano-D'Angelo; K E Blick
Journal:  J Clin Invest       Date:  1987-03       Impact factor: 14.808

Review 7.  Diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the Subcommittee on Protein C and Protein S, International Committee on Thrombosis and Haemostasis.

Authors:  R A Marlar; R R Montgomery; A W Broekmans
Journal:  J Pediatr       Date:  1989-04       Impact factor: 4.406

8.  Prognostic factors of severe infectious purpura in children.

Authors:  F Leclerc; R Beuscart; B Guillois; J F Diependaele; G Krim; D Devictor; Y Bompard; T van Albada
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

9.  Activation and complexation of protein C and cleavage and decrease of protein S in plasma of patients with intravascular coagulation.

Authors:  M J Heeb; D Mosher; J H Griffin
Journal:  Blood       Date:  1989-02       Impact factor: 22.113

10.  Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.

Authors:  J H Griffin; D F Mosher; T S Zimmerman; A J Kleiss
Journal:  Blood       Date:  1982-07       Impact factor: 22.113

View more
  19 in total

Review 1.  Recognition, treatment and complications of meningococcal disease.

Authors:  F A Riordan; A P Thomson
Journal:  Paediatr Drugs       Date:  1999 Oct-Dec       Impact factor: 3.022

Review 2.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

3.  Disseminated intravascular coagulation score is associated with mortality for children with shock.

Authors:  Robinder G Khemani; Robert D Bart; Todd A Alonzo; George Hatzakis; Douglas Hallam; Christopher J L Newth
Journal:  Intensive Care Med       Date:  2008-09-18       Impact factor: 17.440

4.  Global Case-Fatality Rates in Pediatric Severe Sepsis and Septic Shock: A Systematic Review and Meta-analysis.

Authors:  Bobby Tan; Judith Ju-Ming Wong; Rehena Sultana; Janine Cynthia Jia Wen Koh; Mark Jit; Yee Hui Mok; Jan Hau Lee
Journal:  JAMA Pediatr       Date:  2019-04-01       Impact factor: 16.193

Review 5.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

6.  [Sepsis-associated Purpura Fulminans International Registry--Europe (SAPFIRE)].

Authors:  F M Brunkhorst; V Patchev
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-10-29       Impact factor: 0.840

Review 7.  The problem of sepsis. An expert report of the European Society of Intensive Care Medicine.

Authors: 
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Protein C as an early marker of severe septic complications in diffuse secondary peritonitis.

Authors:  Aleksandar Karamarkovic; Dejan Radenkovic; Natasa Milic; Vesna Bumbasirevic; Branislav Stefanovic
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

Review 9.  Management of sepsis and septic shock in infants and children.

Authors:  N von Rosenstiel; I von Rosenstiel; D Adam
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 10.  Coagulation disorders in septic shock.

Authors:  L G Thijs; J P de Boer; M C de Groot; C E Hack
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.